Skip to main content
. 2024 Apr 22;39(6):1208–1221. doi: 10.1093/humrep/deae076

Figure 4.

Figure 4.

Changes in bone mineral density (BMD) from baseline at 6 months. The mean percentage change from baseline was <1% in all three groups (placebo, 75 mg and 200 mg with ABT) in the lumbar spine, femoral neck, and total hip. Error bars represent 95% Cls. ABT: add-back therapy; diff: difference; LGX: linzagolix; LSM: least square mean; OR: odds ratio; PBO: placebo.